IA
WST icon

Inspire Advisors’s West Pharmaceutical WST Stock Holding History

Inspire Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$904K Sell
2,512
-571
-19% -$175K 0.06% 238
2026
Q1 		$773K Buy
3,083
+929
+43% +$231K 0.06% 245
2025
Q4 		$593K Sell
2,154
-378
-15% -$103K 0.05% 282
2025
Q3 		$664K Buy
2,532
+101
+4% +$24.5K 0.06% 243
2025
Q2 		$532K Buy
2,431
+788
+48% +$168K 0.06% 277
2025
Q1 		$368K Sell
1,643
-284
-15% -$78.3K 0.04% 310
2024
Q4 		$631K Buy
1,927
+309
+19% +$97.2K 0.08% 186
2024
Q3 		$486K Buy
1,618
+237
+17% +$72.6K 0.06% 244
2024
Q2 		$455K Buy
1,381
+23
+2% +$8.13K 0.06% 228
2024
Q1 		$537K Buy
1,358
+238
+21% +$88K 0.07% 195
2023
Q4 		$394K Sell
1,120
-1,234
-52% -$437K 0.06% 222
2023
Q3 		$883K Buy
2,354
+1,457
+162% +$563K 0.16% 60
2023
Q2 		$343K Buy
897
+6
+0.7% +$2.14K 0.07% 143
2023
Q1 		$309K Buy
+891
New +$260K 0.07% 109
2021
Q1 		– Sell
-5
Closed -$1K – 738
2020
Q4 		$1K Buy
+5
New +$1.4K ﹤0.01% 770

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Inspire Advisors's WST Position: Q2 2026 in Review

Inspire Advisors reduced its West Pharmaceutical (WST) stake by 19% in Q2 2026, selling an estimated $175K and leaving 2,512 shares worth $904K. The position accounts for 0.06% of the portfolio, ranked #238.

Inspire Advisors first reported a position in WST in Q4 2020 and has held it in 15 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Inspire Advisors held 2,512 shares of West Pharmaceutical worth $904K as of Q2 2026.
  • Inspire Advisors sold 571 West Pharmaceutical shares in Q2 2026, an estimated $175K.
  • West Pharmaceutical made up 0.06% of Inspire Advisors's portfolio in Q2 2026, its #238 holding.
  • Inspire Advisors first reported a position in West Pharmaceutical in Q4 2020 and has held it in 15 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.